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HRQL instrument has been demonstrated in this study
sample. The results indicate that HRQL is a multidimen-
sional construct, which is composed of the dimensions of
physical well-being, social well-being, emotional well-
being, and functional well-being. The HRQL measure-
ment model is universally applicable, irrespective of race
and/or ethnicity, and the factor loadings are the same
across the three groups. The findings indicate that one's
"spiritual beliefs," a social factor, is the most significant
determinant of HRQL followed by a clinical attribute,
performance status.
CONCLUSION: HRQL assessment plays a crucial role
in health services research and clinical practice. It is
hoped that this research has furthered the discussion on
the social and clinical determinants of HRQL. The appli-
cation of a HRQL instrument using confirmatory factor
analysis in multiple racial/ethnic groups in this study has
demonstrated a new methodological approach to valida-
tion research.
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A RETROSPECTIVE APPROACH TO EVALUATE
QALY: ESTIMATION OF HEALTH UTILITY
INDEX FROM THE SF-36 IN A MANAGED
CARE POPULATION
Sengupta N. Nichol M
University of Southern California, Los Angeles, CA, USA
Quality adjusted life years (QALYs) are well recognized as
a valid measure for outcomes in cost-effectiveness analyses.
However, it is difficult to obtain a summary utility score
from health status measure such as the SF-36.
OBJECTIVE: To predict a summary utility score (repre-
sented by HUI) from the scores on the SF-36.
METHODS: A structural equation framework was ap-
plied to data collected from 1992 to 1995 on the South-
ern California Kaiser Permanente population (n = 5,794).
An instrumental variable (IV) method mitigated the endo-
geneity in estimating the HUI(MarklI). Socioeconomic
and disease variables were used as covariates. A split-
sample analysis provided cross-validation.
RESULT: This model predicted 33.68% of the observed
variance in HUI index scores with an adjusted R2 of
0.3335. Observed HUI index scores were distributed with
a mean of 0.7963 and std. deviation of 0.1796. Parame-
ter estimates of most of the SF-36 components (except
General Health & Social Functioning) showed statistical
significance at Ci = 0.05 level. People with high chronic
disease scores were found to have low SF-36 scores, and
parameter estimates of this covariate were also found sta-
tistically significant at Ci = 0.05 level in all structural
equations. However, all the socioeconomic variables
showed statistical insignificance. Comparison of "Fore-
casting" and "Estimation" sub-samples showed satisfac-
tory results during cross-validation.
CONCLUSION: Result of this study provides a quantita-
tive link between two important measures of health sta-
tus. The present model can be used to estimate overall
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health utility summary scores from previous studies using
the SF-36.
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HEALTH UTILITIES INDEX: FURTHER EVIDENCE
OF RESPONSIVENESS
Torrance GW,,2. Feeny 0 1, Furlong W', Barr RO', DePauw S'
'McMaster University. Hamilton, Ontario, Canada; 21nnovus
Research Inc., Burlington, Ontario, Canada
OBJECTIVES: To assess the responsiveness of the Health
Utilities Index 3 (HUB) to measure changes in health sta-
tus and associated health-related quality of life (HRQL)
during the treatment process for children receiving
"maintenance" chemotherapy for acute lymphoblastic
leukemia. To compare results with those of HUI2 which
demonstrated statistically significant responsiveness in
this patient population.
METHODS: All eligible children (n = 18) were assessed
at weekly intervals with multiple instruments, including
the HUI IS-item questionnaire, through a three-week cy-
cle of therapy, by a single research nurse blinded to the
study objectives and week in treatment cycle. High dose
corticosteroids administered during the first five days of
the cycle were expected to have a dramatic adverse effect
on HRQL in week 2 that would be statistically signifi-
cant, even in this small sample. Responsiveness was as-
sessed using AN OVA, paired t-test, intra-class correla-
tion (ICC) and effect size.
RESULTS: Repeated measures ANOVA over the three
weeks indicated that the global HUB score was respon-
sive (p < 0.05) and the effect was due to changes in three
attributes: ambulation, emotion, and pain (each p <
0.05). Paired t-test of weeks 1 and 2 was statistically sig-
nificant (p < 0.001). ICC of responsiveness for weeks 1
and 2 was 0.45. Effect size for weeks 1 and 2 is 2.80. All
of the results are either the same or better than compara-
bly computed HUl2 results on the same patients.
CONCLUSIONS: In this patient population, HUB utility
scores are responsive, and the effect is due to changes in
attributes expected on the basis of conventional clinical
meaures. Moreover, HUB is slightly more responsive
than HUI2. Although results cannot necessarily be gener-
alized to other patient populations, the study adds to the
cumulative evidence on HUI responsiveness.
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SURVEY STRATEGIES IN THE REVISION OF
THE GUIDELINES FOR ECONOMIC
EVALUATION: CANADA
Glennie JL, BaladiJF, Berka C, Hubbard E. Menon 0,
Otten N, Riviere M. Torrance G
CCOHTA Guidelines Review Committee, Ottawa,
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In 1994 the Guidelines for Economic Evaluations of
Pharmaceuticals: Canada (1st ed) was published, and the
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Canadian Coordinating Office for Health Technology
Assessment (CCOHTA) was assigned with its mainte-
nance. In 1996, CCOHTA struck a Committee of experi-
enced stakeholders to review the Guidelines.
METHODS: The Committee distributed an initial survey
(n = 1,500), directed specifically to those in economic
evaluation research ("doers"), and to those who use the
results for decision-making ("users"). Results from this
survey guided the creation of the 2nd edition of the
Guidelines. The survey process was repeated with a draft
of the 2nd edition, and focused on the degree to which
changes to the Guidelines met their objectives and were
an improvement over the 1st edition.
RESULTS: Respondents to both surveys were compara-
be in proportion and composition, with the majority of
respondents being Canadian in origin (75-78%) and rep-
resenting the doers (45--46%). Responses to the initial
survey (10% response rate) suggested a need to clarify the
Guidelines' audience. With this in mind, the Committee
confirmed that the document should provide guidance for
"doers" of evaluations but that this was for the purposes
of providing a clear, comprehensive and scientifically sat-
isfactory report for "users." The initial survey also identi-
fied key areas of concern, which determined the changes
introduced to the 2nd edition. This encompassed the fol-
lowing areas: format changes, cost issues, portability/gen-
eralizability, sensitivity analysis and statistics, HRQOU
QALYs, WTP/CBA, equity, limitations/assumptions, sub-
group analysis, and meta-analysis. The responses to the
follow-up survey (50% response rate) indicated that the
goals of the revision process were achieved and provided
an improvement over the 1st edition (70-80% agreement
rating). Academics and users felt that the Guidelines were
realistic, while less enthusiastic support came from gov-
ernments and doers.
CONCLUSIONS: Survey methodologies are an effective
means of focusing efforts in the Guideline review process.
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